Clovis Oncology News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

19.09.17	NBRV Leaps On Study Data, CSII Takes A Hit, CLVS Abuzz, New Dimension For DMTX (RTTNews)
15.09.17	Biotech Stocks on Investors' Radar -- Clovis Oncology, Dermira, Editas Medicine, and Endocyte (PR Newswire)
13.09.17	Clovis Oncology’s Rucaparib ARIEL3 Study Data Published in The Lancet (Businesswire)
08.09.17	Clovis Oncology Presents Comprehensive Dataset from Successful Phase 3 ARIEL3 Maintenance Treatment Trial of Rucaparib in Advanced Ovarian Cancer at ESMO 2017 (Businesswire)
01.08.17	Gainers & Losers Of July 31: SBBP, AKCA, ACRX, ICPT, ZYNE... (RTTNews)
24.07.17	Technical Snapshots for These Biotech Stocks -- Exelixis, Celldex Therapeutics, Clovis Oncology, and Geron (PR Newswire)
21.06.17	Biopharma Stock Breakouts With Significant Developments and Market Activity (PR Newswire)
21.06.17	Biopharma Stock Breakouts With Significant Developments and Market Activity (PR Newswire)
21.06.17	Key Pharma Stocks With Advanced Developments and Breakthrough Discoveries (PR Newswire)
21.06.17	Key Pharma Stocks With Advanced Developments and Breakthrough Discoveries (PR Newswire)
20.06.17	AMGN's Xgeva To Face FDA In Feb, Double Treat For LPCN, SGEN Drops Cascade (RTTNews)
20.06.17	Gainers & Losers Of June 19: ARNA, NVDQ, CLVS, RWLK, CLSN... (RTTNews)
07.04.17	Muskingum University Installs Dr. Susan S. Hasseler As Its 21st President (PR Newswire)
07.04.17	Research Reports Initiation on Biotech Stocks -- Sarepta Therapeutics, Galena Biopharma, Anthera Pharma, and Clovis Oncology (PR Newswire)
06.04.17	Global Oncology Market Gains Ground, Driven by Innovative Cancer Treatment Therapies (PR Newswire)
17.03.17	5 Biotech Companies Set for Major Breakouts in 2017 (PR Newswire)
15.03.17	Gainers & Losers Of Mar.14: CVRS, OCX, OFIX, PETX, AMPH... (RTTNews)
21.02.17	Biotech Stocks under Scanner -- ACADIA Pharma, Clovis Oncology, Galena Biopharma, and Northwest Biotherapeutics (PR Newswire)
13.01.17	Technical Reports on Biotech Stocks -- Clovis Oncology, Galena Biopharma, and ACADIA Pharma (PR Newswire)
13.01.17	Gainers & Losers Of The Day: TBIO, IMMU, SGMO, BIOC, APRI (RTTNews)
20.12.16	CLVS Gets FDA Nod, PBYI Leaves Big Board, LOXO Hits All-time High, CNAT On Watch (RTTNews)
07.11.16	Six Late Stage Drugs That Bit The Dust Recently (RTTNews)
28.09.16	Clovis Oncology Announces Rucaparib Data Presentations at ESMO 2016 Congress (Businesswire)
24.08.16	Clovis Oncology Adding To Yesterday's Substantial Gain (RTTNews)
24.08.16	LCI Vaults On Bright Outlook, OSUR Gets Zika Contract, CLVS To Face FDA In Feb. (RTTNews)
29.05.16	Biotech Stocks Facing FDA Decision In June (RTTNews)
11.04.16	BSX Recalls Fetch 2 Catheter, CLVS Awaits FDA Panel Vote, LLY, AZN On Watch (RTTNews)
03.04.16	Biotech Stocks Facing FDA Decision In April (RTTNews)
16.02.16	CLVS Gets Panel Date, XBIO Abuzz, FDA Says No To Broader Use Of Zetia, Vytorin (RTTNews)
30.09.15	Soothing Balm For Avita, NVAX Gets Booster Shot, RVNC On The Move (RTTNews)
23.09.15	Clovis Oncology Announces Data Presentations at 2015 European Cancer Congress (Businesswire)
12.08.15	INGN Lifts Outlook, BCLI Awaits DSMB Review, TRVN To Report Data Next Month (RTTNews)
03.08.15	Clovis Oncology Completes U.S., E.U. Regulatory Submissions For Rociletinib (RTTNews)
02.07.15	GMED Expands Product Portfolio, CVM On Track, TCON To Get $3 Mln, REPH On Watch (RTTNews)
07.04.15	Clovis Oncology Gets FDA Breakthrough Therapy Designation For Rucaparib (RTTNews)
20.11.14	CBMG To Keep On Your Radar, CEMP Gets Funding, MACK On Fast Track (RTTNews)
20.11.14	Initial Data from Ongoing Phase 2 ARIEL2 Study of Rucaparib in Ovarian Cancer Demonstrate Encouraging Clinical Activity and Safety in both BRCA Mutant and BRCAness Patients (Businesswire)
18.11.14	ACT Buys AGN, NBS Needs A Close Watch, No Pain For TRVN, TKMR Does A Deal (RTTNews)
28.09.14	Data from Ongoing Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Safety and Clinical Activity, Validate Differentiated Strategy (Businesswire)
07.08.14	Clovis Oncology Q2 Loss Widens - Quick Facts (RTTNews)
23.06.14	Clovis Oncology Initiates TIGER 2 Non-small Cell Lung Cancer Study With CO-1686 (RTTNews)
20.05.14	CLVS Up After-Hours, ECYT On The Back Foot, IMMU Making News, NNVC Cashed Up (RTTNews)
08.05.14	Clovis Oncology Q1 Loss Widens (RTTNews)
28.02.14	Clovis Oncology Q4 Loss Widens - Quick Facts (RTTNews)
13.01.14	Clovis Announces Development Milestones - Quick Facts (RTTNews)
23.12.13	Clovis Oncology Announces CO-1686 Clinical Data Accepted as Oral Presentation at 2014 European Lung Cancer Conference (Businesswire)
20.11.13	ATRC On The GO, BMRN Gets Panel's Nod, CLVS Opens Purse Strings, POZN Surges (RTTNews)
19.11.13	Clovis Oncology Buys EOS S.p.A. (RTTNews)
19.11.13	Clovis Oncology Acquires EOS (Ethical Oncology Science) S.p.A. to Gain Rights to Lucitanib, a Unique Dual-Selective Phase II FGFR/VEGFR Inhibitor (Businesswire)
28.10.13	Pre-market Movers For Oct 28 (BIIB, MRK, MOS, BKW, DNDN, CLVS, SOHU, CYOU, SNTA) (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	29.72	2.13 %	K V
Holcim	92.20	1.45 %	K V
Sika	230.00	1.28 %	K V
Kuehne+Nagel Int	204.50	1.24 %	K V
Swisscom	515.00	1.18 %	K V
Novartis	98.14	-0.45 %	K V
Roche Hldg G	288.80	-0.86 %	K V
CieFinRichemont	176.15	-0.87 %	K V
Givaudan	3’875.00	-1.07 %	K V
Sonova Hldg	305.50	-1.13 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Clovis Oncology Inc.

Aktien Top/Flop

Meistgelesene Nachrichten